Mathematical Models can Assist in Broadening use of Immuno-oncology Drugs to Treat Autoimmunity
Connecting Cancer and Autoimmunity "The dosing regimens in oncology may not directly inform the optimal…
CertaraOctober 31, 2024
RAPS Sponsored Webcast: Optimizing Pediatric Oncology Drug Development: A Comprehensive Overview
Developing safe and effective oncology medications for children presents unique challenges due to ethical considerations…
CertaraOctober 17, 2024
Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization
The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…
CertaraAugust 19, 2024
Model-Informed Confidence in Oncology Dose Selection
Discover an oncology-focused company that gained confidence in their dose selection for an AML trial…
CertaraAugust 9, 2024
Certara’s MIDD Oncology Capabilities
Improve Oncology Study Decisions with Certara's MIDD Team Transcript: The pace of oncology drug…
CertaraAugust 7, 2024
